Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (151-160 of 775) with videos related to

Pageof 78
Sort By:
Communicable Diseases Intelligence Quarterly Report|August 30, 2007
Creutzfeldt-Jakob disease: Australian surveillance update to March 2007Genevieve M Klug, Alison Boyd, Victoria Lewis, et al.
Journal of Neurochemistry|November 5, 2005
The beta-amyloid peptide of Alzheimer's disease decreases adhesion of vascular smooth muscle cells to the basement membraneSu San Mok, Dusan Losic, Colin J Barrow, et al.
Molecular Psychiatry|November 24, 2023
Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer's diseaseYan Lian, Yu-Juan Jia, Joelyn Wong, et al.
Journal of Virology|December 20, 2013
Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethalityBradley M Coleman, Christopher F Harrison, Belinda Guo, et al.
Biochemistry|January 9, 2008
Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synucleinDavid P Smith, Deborah J Tew, Andrew F Hill, et al.
Neurobiology of Disease|October 26, 2005
Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection controlSteven J Collins, Victoria Lewis, Marcus W Brazier, et al.
Free Radical Biology & Medicine|November 15, 2011
Elevated labile Cu is associated with oxidative pathology in Alzheimer diseaseSimon A James, Irene Volitakis, Paul A Adlard, et al.
Brain Research|January 11, 2011
The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domainsFrances Corrigan, Chi L L Pham, Robert Vink, et al.
Seminars in Nuclear Medicine|December 19, 2016
Aβ-amyloid and Tau Imaging in DementiaVictor L Villemagne, Vincent Doré, Pierrick Bourgeat, et al.
Protein Engineering, Design & Selection : PEDS|October 18, 2008
Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomersRemy Robert, Olan Dolezal, Lynne Waddington, et al.
Pageof 78

Showing results (151-160 of 775) with videos related to

Sort By:
Pageof 78
Communicable Diseases Intelligence Quarterly Report|August 30, 2007
Creutzfeldt-Jakob disease: Australian surveillance update to March 2007Genevieve M Klug, Alison Boyd, Victoria Lewis, et al.
Journal of Neurochemistry|November 5, 2005
The beta-amyloid peptide of Alzheimer's disease decreases adhesion of vascular smooth muscle cells to the basement membraneSu San Mok, Dusan Losic, Colin J Barrow, et al.
Molecular Psychiatry|November 24, 2023
Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer's diseaseYan Lian, Yu-Juan Jia, Joelyn Wong, et al.
Journal of Virology|December 20, 2013
Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethalityBradley M Coleman, Christopher F Harrison, Belinda Guo, et al.
Biochemistry|January 9, 2008
Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synucleinDavid P Smith, Deborah J Tew, Andrew F Hill, et al.
Neurobiology of Disease|October 26, 2005
Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection controlSteven J Collins, Victoria Lewis, Marcus W Brazier, et al.
Free Radical Biology & Medicine|November 15, 2011
Elevated labile Cu is associated with oxidative pathology in Alzheimer diseaseSimon A James, Irene Volitakis, Paul A Adlard, et al.
Brain Research|January 11, 2011
The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domainsFrances Corrigan, Chi L L Pham, Robert Vink, et al.
Seminars in Nuclear Medicine|December 19, 2016
Aβ-amyloid and Tau Imaging in DementiaVictor L Villemagne, Vincent Doré, Pierrick Bourgeat, et al.
Protein Engineering, Design & Selection : PEDS|October 18, 2008
Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomersRemy Robert, Olan Dolezal, Lynne Waddington, et al.
Pageof 78